
Drug that targets ACE2 receptors may work against new covid variants
5 December 2022
A drug that is approved for treating gallstones and liver conditions inhibits cells' ACE2 receptors, which the coronavirus' spike protein binds to

5 December 2022
A drug that is approved for treating gallstones and liver conditions inhibits cells' ACE2 receptors, which the coronavirus' spike protein binds to

28 July 2022
Unlike existing treatments that focus on rehabilitation or reducing the risk of an additional stroke, the experimental drug targets the "stickiness" that can prevent injured brain tissue from functioning as it should